Quantum Queen
OP
Lnova
:
I'm just relaying the Data there's 2 Ways to Win IF you know it's a Drop then trade the Drop (SHORT) then when you FEEL it's a spike back up for a BULL Cover (Sell) your SHORT then renter for a BULL Trade. Try not to be One way it's about being Universal and SEEING EVERYTHING not one way.
Lnova
:
Greenlane Announces Exclusive Distribution Agreement With Safety Strips Tech Corp Fentanyl, Xylazine and Drink Spike Detection Test Strips it could save people’s lives
$Treace Medical Concepts (TMCI.US)$Recent Highlights• Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023 • Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted EBITDA loss improved 45% to ($5.1) million in the third quarter 2024 compared to ($9.2) million for the same period in 2023 • Announces first entry into high volume osteotomy market with Nanoplasty™ 3D Minimally Invasive Bunion ...
$Treace Medical Concepts (TMCI.US)$TMCI is on unchartered territory, but I can see litile more pain and it can touch $3.5 level before stabilizing around it. Be carefull there is something big with this stock or management is hiding. Waiting for more clarities from management.
$Treace Medical Concepts (TMCI.US)$Will start to pick up steam in 20 min. Capital inflow is way up which doesnt match the price decrease. Usually means an institution is buying the shares that were sold at around 7.00-7.50. Once they get average necessary price will run back up. Im in at 4.18
Treace Medical Concepts Stock Forum
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
FREY= SHORTED from $1.90s $2s
BNZI= SHORTED from $3.70s SHORTS 🩳 waiting for $4s one last Spike
ELWS= SHORTED from $8s, $7s first entry SHORT
DYXY= SHORTED from $22s
TMCI= SHORTED from $8s
GNLN= SHORTED from $4s
CIFR= SHORTED from $7s
IHRT= SHORTED from $2.80s
$Invesco QQQ Trust (QQQ.US)$ $AMC Entertainment (AMC.US)$ $GameStop (GME.US)$ $NVIDIA (NVDA.US)$ $SPDR S&P 500 ETF (SPY.US)$
Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023
•
Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted EBITDA loss improved 45% to ($5.1) million in the third quarter 2024 compared to ($9.2) million for the same period in 2023
•
Announces first entry into high volume osteotomy market with Nanoplasty™ 3D Minimally Invasive Bunion ...
No comment yet